Chris Tang, MD, PhD is an Assistant Investigator at The Feinstein Institute for Medical Research. Dr. Tang is an expert in neuroimaging as well as in the clinical study of neurodegenerative disease, and he also has a strong background in statistics. His research has focused on the study of abnormal metabolic networks in the brain that are related to motor and cognitive symptoms of neurodegenerative diseases such as Parkinson’s disease and Huntington’s disease. He is also investigating how multiple biomarkers seen in images of brain networks can lead to accurate differential diagnosis of early-stage disease in patients with clinically uncertain symptoms of parkinsonism. He has published several first-author research articles in such prestigious journals as Lancet Neurology. His work was recognized recently by a 2013 Competitive Faculty Award from The Feinstein Institute.
Dr. Tang graduated with an MD from Beijing Medical University, China, in 1995. In 2004 he earned his MS in biopsychology and behavioral neuroscience from Rutgers University in New Jersey; he earned his MS in biostatistics, also from Rutgers, the following year. Dr. Tang joined the Center for Neurosciences at The Feinstein Institute for Medical Research in 2005, and earned a PhD degree in molecular medicine through the Institute’s Elmezzi Graduate School of Molecular Medicine in 2009.